We intratumorally injected sorted CX3CR1+CD206+ macrophages from day 12 neoAg SLP vax-treated mice into a separate cohort of Y1.7LI tumor-bearing mice on days 4, 7, and 10 post-transplant and initiated neoAg SLP vax on day 7 (Figure 7B). This evidence concerns the gene MRC1 and neoplasm.